ClinicalTrials.Veeva

Menu

Actigraphy and Neonatal Abstinence Syndrome (ACTINEO)

C

Caen University Hospital

Status

Unknown

Conditions

Neonatal Abstinence Syndrome

Treatments

Diagnostic Test: Actigraphy

Study type

Interventional

Funder types

Other

Identifiers

NCT03977545
2018-A02290-55

Details and patient eligibility

About

The aim of our study is to analyse the correlation between actigraphy and Lipsitz scoring system in neonatal opioid abstinence syndrome.

Full description

Neonatal opioid abstinence syndrome occurs after birth when opioids were used by the mother during pregnancy.

Many scoring systems, like Lipsitz scoring system, are used to diagnose and manage neonatal abstinence syndrome but they are subjective. The majority of items in these scores are motor skills items.

Actigraphy allows to measure objectively the newborn motricity. We will analyse the correlation between actigraphy and Lipsitz scoring system in four groups of newborns.

Enrollment

50 estimated patients

Sex

All

Ages

Under 1 day old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Newborn > 32 weeks of gestation + 0 day

Exclusion criteria

  • perinatal asphyxia
  • 5- minute Apgar score < 7
  • ante or post-natal brain injury diagnosis
  • upper arm motor deficit
  • hospitalization in intensive care unit
  • neonatal respiratory distress

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 4 patient groups

Newborn with risk of neonatal opioid abstinence syndrome
Other group
Description:
The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 7 days
Treatment:
Diagnostic Test: Actigraphy
Eutrophic term newborn
Other group
Description:
The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days
Treatment:
Diagnostic Test: Actigraphy
Term newborn with low birth weight
Other group
Description:
The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days
Treatment:
Diagnostic Test: Actigraphy
Eutrophic premature newborn
Other group
Description:
The newborns will have actigraphy during 30 minutes and Lipsitz scoring system twice a day during 2 days
Treatment:
Diagnostic Test: Actigraphy

Trial contacts and locations

1

Loading...

Central trial contact

Elodie LECORPS; Bernard GUILLOIS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems